These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19115328)

  • 21. Mutagenesis of the central hydrophobic cluster in Abeta42 Alzheimer's peptide. Side-chain properties correlate with aggregation propensities.
    de Groot NS; Aviles FX; Vendrell J; Ventura S
    FEBS J; 2006 Feb; 273(3):658-68. PubMed ID: 16420488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing the folding free-energy landscapes of Abeta42 variants with different aggregation properties.
    Mitternacht S; Staneva I; Härd T; Irbäck A
    Proteins; 2010 Sep; 78(12):2600-8. PubMed ID: 20589631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein.
    Miyamae Y; Kurisu M; Murakami K; Han J; Isoda H; Irie K; Shigemori H
    Bioorg Med Chem; 2012 Oct; 20(19):5844-9. PubMed ID: 22921742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methyl dynamics of the amyloid-beta peptides Abeta40 and Abeta42.
    Yan Y; Liu J; McCallum SA; Yang D; Wang C
    Biochem Biophys Res Commun; 2007 Oct; 362(2):410-4. PubMed ID: 17709094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verification of the C-terminal intramolecular beta-sheet in Abeta42 aggregates using solid-state NMR: implications for potent neurotoxicity through the formation of radicals.
    Masuda Y; Uemura S; Nakanishi A; Ohashi R; Takegoshi K; Shimizu T; Shirasawa T; Irie K
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3206-10. PubMed ID: 18468894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probing Alzheimer amyloid peptide aggregation using a cell-free fluorescent protein refolding method.
    Arslan PE; Chakrabartty A
    Biochem Cell Biol; 2009 Aug; 87(4):631-9. PubMed ID: 19767826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid-induced conformational transition of the amyloid core fragment Abeta(28-35) and its A30G and A30I mutants.
    Nagarajan S; Ramalingam K; Neelakanta Reddy P; Cereghetti DM; Padma Malar EJ; Rajadas J
    FEBS J; 2008 May; 275(10):2415-27. PubMed ID: 18422968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models.
    van Groen T; Kadish I; Wiesehan K; Funke SA; Willbold D
    ChemMedChem; 2009 Feb; 4(2):276-82. PubMed ID: 19072935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement.
    Morimoto A; Irie K; Murakami K; Masuda Y; Ohigashi H; Nagao M; Fukuda H; Shimizu T; Shirasawa T
    J Biol Chem; 2004 Dec; 279(50):52781-8. PubMed ID: 15459202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FTIR spectroscopic studies on aggregation process of the beta-amyloid 11-28 fragment and its variants.
    Juszczyk P; Kołodziejczyk AS; Grzonka Z
    J Pept Sci; 2009 Jan; 15(1):23-9. PubMed ID: 19023881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A model for studying Alzheimer's Abeta42-induced toxicity in Drosophila melanogaster.
    Finelli A; Kelkar A; Song HJ; Yang H; Konsolaki M
    Mol Cell Neurosci; 2004 Jul; 26(3):365-75. PubMed ID: 15234342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid beta-protein: monomer structure and early aggregation states of Abeta42 and its Pro19 alloform.
    Bernstein SL; Wyttenbach T; Baumketner A; Shea JE; Bitan G; Teplow DB; Bowers MT
    J Am Chem Soc; 2005 Feb; 127(7):2075-84. PubMed ID: 15713083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distance measurement between Tyr10 and Met35 in amyloid beta by site-directed spin-labeling ESR spectroscopy: implications for the stronger neurotoxicity of Abeta42 than Abeta40.
    Murakami K; Hara H; Masuda Y; Ohigashi H; Irie K
    Chembiochem; 2007 Dec; 8(18):2308-14. PubMed ID: 18022992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's Abeta peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s)?
    Bieschke J; Siegel SJ; Fu Y; Kelly JW
    Biochemistry; 2008 Jan; 47(1):50-9. PubMed ID: 18078350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing amyloid-beta protein misfolding from molecular dynamics simulations with explicit water.
    Lee C; Ham S
    J Comput Chem; 2011 Jan; 32(2):349-55. PubMed ID: 20734314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
    Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
    Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Copper inducing Aβ42 rather than Aβ40 nanoscale oligomer formation is the key process for Aβ neurotoxicity.
    Jin L; Wu WH; Li QY; Zhao YF; Li YM
    Nanoscale; 2011 Nov; 3(11):4746-51. PubMed ID: 21952557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral vascular accumulation of Dutch-type Abeta42, but not wild-type Abeta42, in hereditary cerebral hemorrhage with amyloidosis, Dutch type.
    Nishitsuji K; Tomiyama T; Ishibashi K; Kametani F; Ozawa K; Okada R; Maat-Schieman ML; Roos RA; Iwai K; Mori H
    J Neurosci Res; 2007 Oct; 85(13):2917-23. PubMed ID: 17628026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational solution studies of the SDS micelle-bound 11-28 fragment of two Alzheimer's beta-amyloid variants (E22K and A21G) using CD, NMR, and MD techniques.
    Rodziewicz-Motowidło S; Juszczyk P; Kołodziejczyk AS; Sikorska E; Skwierawska A; Oleszczuk M; Grzonka Z
    Biopolymers; 2007 Sep; 87(1):23-39. PubMed ID: 17534931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23.
    Murakami K; Horikoshi-Sakuraba Y; Murata N; Noda Y; Masuda Y; Kinoshita N; Hatsuta H; Murayama S; Shirasawa T; Shimizu T; Irie K
    ACS Chem Neurosci; 2010 Nov; 1(11):747-56. PubMed ID: 22778811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.